Shopping Cart
- Remove All
- Your shopping cart is currently empty
RTIOXA-43 is an orexin receptor agonist with EC50 values of 24 nM for both OX2 and OX1 receptors [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | RTIOXA-43 is an orexin receptor agonist with EC50 values of 24 nM for both OX2 and OX1 receptors [1]. |
Targets&IC50 | OX2:24 nM (EC 50 ), OX1:24 nM (EC 50 ) |
In vivo | In adult (12-month-old) mice, peripheral administration of RTIOXA-43 enhances wakefulness duration, reduces sleep time, and lessens sleep/wake fragmentation. Additionally, RTIOXA-43 improves sleep/wake quality by decreasing the frequency of episodes and extending their duration [2]. |
Molecular Weight | 663.79 |
Formula | C37H37N5O5S |
Cas No. | 2832067-72-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.